Chiron finally received FDA approval to ship its first three lots of flu vaccine. It is the last of the vaccine makers to get the green light to begin supplying vaccine to the market. Chiron has said that it will ship 18 million to 26 million doses this fall after being forced to sit out last flu season after regulators determined that its Liverpool facility had been contaminated.
- read this report from the San Jose Mercury News for more
PLUS: Chiron and XOMA have launched a Phase I trial for the multiple myeloma therapy CHIR-12.12. Release